GSK Spreads Smoking-Cessation Aids To Countries Serious About Quitting
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline plans to introduce its smoking-cessation products to 800 million people over the next four years in countries working to reduce smoking among their populations